Pharma & Biotech

Moderna shares experienced a notable downturn this week, declining nearly 5% on Thursday to close at approximately €21. This sell-off...

Cardiff Oncology's stock continues to navigate challenging market conditions, with its downward trajectory becoming increasingly pronounced. The share price concluded...

Despite posting robust quarterly earnings and continuing its track record of innovation, Thermo Fisher Scientific finds its stock mired in...

Danaher Corporation shareholders are receiving an increased dividend of $0.32 per share today, yet this positive cash return is set...

The stock of biopharmaceutical company aTyr Pharma extended its decline in after-hours trading on Thursday, shedding nearly 6 percent. This...

A prominent speaking opportunity for a biotech CEO typically generates positive market momentum. However, Dr. Shankar Musunuri's participation on a...

Lantheus Holdings finds itself balancing significant legal pressures against a promising new international venture. The biopharmaceutical company faces a series...

Sana Biotechnology's stock registered a solid rebound in today's trading, climbing 4.60% to $3.39. This advance comes after a minor...

Phathom Pharmaceuticals finds itself at a critical juncture, with its stock performance presenting a puzzle to investors. Despite a recent...

A significant new investor has entered the scene, triggering a powerful rally for AnaptysBio shares. Millennium Management, the hedge fund...